Literature DB >> 19362539

A genomic strategy to elucidate modules of oncogenic pathway signaling networks.

Jeffrey T Chang1, Carlos Carvalho, Seiichi Mori, Andrea H Bild, Michael L Gatza, Quanli Wang, Joseph E Lucas, Anil Potti, Phillip G Febbo, Mike West, Joseph R Nevins.   

Abstract

Recent studies have emphasized the importance of pathway-specific interpretations for understanding the functional relevance of gene alterations in human cancers. Although signaling activities are often conceptualized as linear events, in reality, they reflect the activity of complex functional networks assembled from modules that each respond to input signals. To acquire a deeper understanding of this network structure, we developed an approach to deconstruct pathways into modules represented by gene expression signatures. Our studies confirm that they represent units of underlying biological activity linked to known biochemical pathway structures. Importantly, we show that these signaling modules provide tools to dissect the complexity of oncogenic states that define disease outcomes as well as response to pathway-specific therapeutics. We propose that this model of pathway structure constitutes a framework to study the processes by which information propogates through cellular networks and to elucidate the relationships of fundamental modules to cellular and clinical phenotypes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19362539      PMCID: PMC2694616          DOI: 10.1016/j.molcel.2009.02.030

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  38 in total

1.  Towards a proteome-scale map of the human protein-protein interaction network.

Authors:  Jean-François Rual; Kavitha Venkatesan; Tong Hao; Tomoko Hirozane-Kishikawa; Amélie Dricot; Ning Li; Gabriel F Berriz; Francis D Gibbons; Matija Dreze; Nono Ayivi-Guedehoussou; Niels Klitgord; Christophe Simon; Mike Boxem; Stuart Milstein; Jennifer Rosenberg; Debra S Goldberg; Lan V Zhang; Sharyl L Wong; Giovanni Franklin; Siming Li; Joanna S Albala; Janghoo Lim; Carlene Fraughton; Estelle Llamosas; Sebiha Cevik; Camille Bex; Philippe Lamesch; Robert S Sikorski; Jean Vandenhaute; Huda Y Zoghbi; Alex Smolyar; Stephanie Bosak; Reynaldo Sequerra; Lynn Doucette-Stamm; Michael E Cusick; David E Hill; Frederick P Roth; Marc Vidal
Journal:  Nature       Date:  2005-09-28       Impact factor: 49.962

Review 2.  Signaling interplay in Ras superfamily function.

Authors:  Natalia Mitin; Kent L Rossman; Channing J Der
Journal:  Curr Biol       Date:  2005-07-26       Impact factor: 10.834

3.  Transcript and protein expression profiles of the NCI-60 cancer cell panel: an integromic microarray study.

Authors:  Uma T Shankavaram; William C Reinhold; Satoshi Nishizuka; Sylvia Major; Daisaku Morita; Krishna K Chary; Mark A Reimers; Uwe Scherf; Ari Kahn; Douglas Dolginow; Jeffrey Cossman; Eric P Kaldjian; Dominic A Scudiero; Emanuel Petricoin; Lance Liotta; Jae K Lee; John N Weinstein
Journal:  Mol Cancer Ther       Date:  2007-03-05       Impact factor: 6.261

Review 4.  Ras, PI(3)K and mTOR signalling controls tumour cell growth.

Authors:  Reuben J Shaw; Lewis C Cantley
Journal:  Nature       Date:  2006-05-25       Impact factor: 49.962

5.  Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature.

Authors:  Keith S Hoek; Natalie C Schlegel; Patricia Brafford; Antje Sucker; Selma Ugurel; Rajiv Kumar; Barbara L Weber; Katherine L Nathanson; David J Phillips; Meenhard Herlyn; Dirk Schadendorf; Reinhard Dummer
Journal:  Pigment Cell Res       Date:  2006-08

Review 6.  The NCI60 human tumour cell line anticancer drug screen.

Authors:  Robert H Shoemaker
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

7.  Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.

Authors:  Kian-Huat Lim; Christopher M Counter
Journal:  Cancer Cell       Date:  2005-11       Impact factor: 31.743

8.  An integrated genomic analysis of human glioblastoma multiforme.

Authors:  D Williams Parsons; Siân Jones; Xiaosong Zhang; Jimmy Cheng-Ho Lin; Rebecca J Leary; Philipp Angenendt; Parminder Mankoo; Hannah Carter; I-Mei Siu; Gary L Gallia; Alessandro Olivi; Roger McLendon; B Ahmed Rasheed; Stephen Keir; Tatiana Nikolskaya; Yuri Nikolsky; Dana A Busam; Hanna Tekleab; Luis A Diaz; James Hartigan; Doug R Smith; Robert L Strausberg; Suely Kazue Nagahashi Marie; Sueli Mieko Oba Shinjo; Hai Yan; Gregory J Riggins; Darell D Bigner; Rachel Karchin; Nick Papadopoulos; Giovanni Parmigiani; Bert Vogelstein; Victor E Velculescu; Kenneth W Kinzler
Journal:  Science       Date:  2008-09-04       Impact factor: 47.728

9.  Neural computing in cancer drug development: predicting mechanism of action.

Authors:  J N Weinstein; K W Kohn; M R Grever; V N Viswanadhan; L V Rubinstein; A P Monks; D A Scudiero; L Welch; A D Koutsoukos; A J Chiausa
Journal:  Science       Date:  1992-10-16       Impact factor: 47.728

10.  Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks.

Authors:  Diego di Bernardo; Michael J Thompson; Timothy S Gardner; Sarah E Chobot; Erin L Eastwood; Andrew P Wojtovich; Sean J Elliott; Scott E Schaus; James J Collins
Journal:  Nat Biotechnol       Date:  2005-03       Impact factor: 54.908

View more
  44 in total

Review 1.  Identification of aberrant pathways and network activities from high-throughput data.

Authors:  Jinlian Wang; Yuji Zhang; Catalin Marian; Habtom W Ressom
Journal:  Brief Bioinform       Date:  2012-01-27       Impact factor: 11.622

2.  Bayesian Learning in Sparse Graphical Factor Models via Variational Mean-Field Annealing.

Authors:  Ryo Yoshida; Mike West
Journal:  J Mach Learn Res       Date:  2010-05-01       Impact factor: 3.654

3.  A pathway-based classification of human breast cancer.

Authors:  Michael L Gatza; Joseph E Lucas; William T Barry; Jong Wook Kim; Quanli Wang; Matthew D Crawford; Michael B Datto; Michael Kelley; Bernard Mathey-Prevot; Anil Potti; Joseph R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-24       Impact factor: 11.205

4.  Separate enrichment analysis of pathways for up- and downregulated genes.

Authors:  Guini Hong; Wenjing Zhang; Hongdong Li; Xiaopei Shen; Zheng Guo
Journal:  J R Soc Interface       Date:  2013-12-18       Impact factor: 4.118

5.  Lauriston S. Taylor Lecture on radiation protection and measurements: what makes particle radiation so effective?

Authors:  Eleanor A Blakely
Journal:  Health Phys       Date:  2012-11       Impact factor: 1.316

6.  Potential biomarkers for sensitivity of gallbladder cancer cells to gemcitabine.

Authors:  Chao Yang; Ming Xu; Huo-Jian Shen; Hong-Yi Zhu; Fu Li; Min He; Tao Chen; Jian Wang; Wei-Jin Shi; Fu Ji
Journal:  Int J Clin Exp Pathol       Date:  2014-01-15

7.  The dawn of a new era in cell signalling research.

Authors:  Stephan M Feller
Journal:  Cell Commun Signal       Date:  2010-05-24       Impact factor: 5.712

8.  A gene expression signature of RAS pathway dependence predicts response to PI3K and RAS pathway inhibitors and expands the population of RAS pathway activated tumors.

Authors:  Andrey Loboda; Michael Nebozhyn; Rich Klinghoffer; Jason Frazier; Michael Chastain; William Arthur; Brian Roberts; Theresa Zhang; Melissa Chenard; Brian Haines; Jannik Andersen; Kumiko Nagashima; Cloud Paweletz; Bethany Lynch; Igor Feldman; Hongyue Dai; Pearl Huang; James Watters
Journal:  BMC Med Genomics       Date:  2010-06-30       Impact factor: 3.063

Review 9.  Divide and conquer: progress in the molecular stratification of cancer.

Authors:  Patrick Tan
Journal:  Yonsei Med J       Date:  2009-08-19       Impact factor: 2.759

Review 10.  Cancer systems biology: a network modeling perspective.

Authors:  Pamela K Kreeger; Douglas A Lauffenburger
Journal:  Carcinogenesis       Date:  2009-10-27       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.